Ipilimumab trials for Advanced Melanoma

All Ipilimumab trials · All Advanced Melanoma trials

Phase breakdown

Recruiting trials studying Ipilimumab for Advanced Melanoma

• A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
  NCT06594991 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 12 locations
• Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
  NCT06295159 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and Relatlimab
  NCT07504796 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Ipilimumab for Advanced Melanoma?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.